Abstract W P191: Patient Compliance High with Long-Term Continuous ECG Monitor
Introduction: Long term ECG monitoring to detect atrial fibrillation in a cryptogenic stroke is now the emerging standard of care. The advent of patch based ECG monitors raises the question of patient compliance with this new modality.
Hypothesis: We assessed the hypothesis that patient compliance, as measured by Leads-On detection for patch based ECG monitoring, is constant over time.
Methods: We performed a retrospective analysis from ZIO® Patch (Patch) devices (iRhythm, San Francisco, CA). The Patch is a continuous recording single lead ECG monitor that can be worn for up to 14 days. The primary endpoint of Leads-On is the percentage of time the device is applied to the patient during the wear period, which was derived from a second channel in the device. The data are gathered by ZEUS software and exported in a CSV file. The compliance data were analyzed overall and in categories at days: 0-1, 1-2, 2 to 7, >7 to 10 and >10 to 14. A secondary endpoint, percent Analyzable Time (percentage of ECG record that was available for detection by the algorithm during the wear period and signifies signal quality), was assessed for the same time increments.
Results: The dataset consisted of 18,885 records. The total wear time ranged from 0.10 up to 14.01 days, with a median of 12.51. The medians and interquartile ranges for the percent Leads On and percent of Analyzable Time were 100% (99.99-100%) and 97.99% (94.64-99.26%). In Table 1, the interquartile ranges for percent Leads On and Analyzable Time was wider when the Patch was worn less than a day, but remains above 74%.
Total wear time in days n Percent Leads On Percent Analyzable Time
Median Interquartile Range Median Interquartile Range
0.10-<1 105 99.65 86.52-100 92.86 74.19-96.97
1-<2 407 100 99.88-100 97.37 90.96-99.02
2-<7 4124 100 100-100 97.96 94.3-99.26
7-<10 2963 100 99.98-100 97.79 94.33-99.19
10+ 11286 100 100-100 98.07 95.00-99.29
Conclusion: Patient compliance with long term ECG patch monitors is high as measured by Leads-On detection. High patient compliance results in a large volume of quality ECG. Further study is needed to compare patient compliance with ECG patch based monitors with other monitoring modalities, particularly in the cryptogenic stroke population.
Author Disclosures: J.C. Lenane: Employment; Significant; iRhythm Technologies. A.J. Fought: Consultant/Advisory Board; Modest; iRhythm. J.H. Alexander: Consultant/Advisory Board; Significant; iRhythm.
- © 2015 by American Heart Association, Inc.